Encuragen

South Korea
Anyang-si, Gyeonggi-do, South Korea

Company profile

Encuragen company profile

Encuragen develops biological therapeutics for the treatment of incurable diseases and the improvement of human health. EncuraGen engages in scientific research to find fundamental cures for patients suffering from various difficult-to-cure diseases, rather than simply alleviating symptoms. EncuraGen is committed to the research and development of novel medicines in order to provide comprehensive therapeutics for cure and care. Furthermore, the company is a specialized, dedicated R&D company engaged in synthetic biology, which will open up a new horizon for prospective industries through the broad, creative application of basic life sciences.

Business identity

Phone number
+82-31-360-3132
Operating status
Active
Company type
For Profit
Founded
2016-01-01, Year

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Series Unknown / 2021-03-01
Last equity funding
Series Unknown
Investors
2

Founders and investors

Investors

Intops InvestmentSTIC Ventures